Luminex Corp (LMNX)

22.77 -0.42  -1.81% NASDAQ Nov 27, 20:00 USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
02/10/2021 Earnings Luminex Corp Fourth Quarter Earnings for 2020 Release
02/10/2021 17:00 EST Misc Luminex Corp Fourth Quarter Earnings Conference Call for 2020
11/02/2020 Earnings Luminex Corp Third Quarter Earnings Result for 2020
11/02/2020 Misc Luminex Corp Third Quarter Earnings Conference Call for 2020
09/23/2020 Dividends Amount: 0.09, Declared Date: Sep 15 2020, Pay Date: Oct 15 2020
08/03/2020 Earnings Luminex Corp Second Quarter Earnings Result for 2020
08/03/2020 Misc Luminex Corp Second Quarter Earnings Conference Call for 2020
06/17/2020 Dividends Amount: 0.09, Declared Date: May 22 2020, Pay Date: Jul 09 2020
05/21/2020 Misc Luminex Corp Annual General Meeting for 2019
05/11/2020 Earnings Luminex Corp First Quarter Earnings Result for 2020
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.luminexcorp.com
  • Investor Relations URL: http://investor.luminexcorp.com/phoenix.zhtml?c=79403&p=irol-irhome
  • HQ State/Province: Texas
  • Sector: Healthcare
  • Industry: Medical Instruments & Supplies
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Feb. 10, 2021
  • Last Earnings Release: Nov. 02, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Sep. 23, 2020
  • Description: Luminex Corp is a biotechnology company that develops, manufactures, and sells proprietary biological testing technologies and products to testing laboratories. The company primarily serves the life sciences industries by selling products used by laboratory professionals and clinical laboratories in performing diagnostics, drug research and discovery, and clinical tests on patients. Luminex's market segments mainly include infectious disease, genetic or inherited disease, personalized medicine, and life sciences research. It offers various solutions in diverse markets, including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, and food safety. The vast majority of the company's revenue is earned in the United States.

Top Fund Holders

Symbol Name Weighting
IUSCX Fisher IIG US Sm Cap Eq 2.57%
GBSCX American Beacon Bahl&Gaynor SmCpGr C 2.16%
CAMSX Cambiar Small Cap Inv 2.11%
CDOFX Crawford Small Cap Dividend 1.66%
BIGTX The Texas I 1.24%
GERM ETFMG Treatments Testing and Adv ETF 1.02%
RNSC First Trust Small Cap US Equity Sel ETF 1.01%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.